The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma
Open accessAbstract
Background: Nasopharyngeal carcinoma (NPC) is one of the most common malignancies in southern China. The China 1992 TNM staging system has been widely used for prognosis prediction of NPC patients in China. Although NPC patients can be classified according to their clinical stage in this system, their prognosis may vary significantly. Method: 280 cases of NPC with clinical follow-up data were collected and expressions of survivin and VEGF in tumor tissues were investigated by immunohistochemistry (IHC). Apoptosis index (AI) in 100 cases of NPC was detected by the TUNEL method. Results: Expression of survivin and VEGF were significantly associated with TNM stage, T-stage and metastasis of NPC. The patients with survivin and VEGF over-expression presented lower 5-year survival rate, as compared to those of low-expression (42.32% vs. 70.54%, 40.1% vs. 67.8%, respectively, P < 0.05), especially in advanced stage patients (36.51% vs. 73.41%, 35.03% vs. 65.22%, respectively, P < 0.05). The 5-year survival rate in NPC patients with survivin and VEGF dual over-expression was significantly lower than that of patients with dual low-expression (18.22% vs. 73.54%, respectively; P = 0.0003). Multivariate analysis indicated that both survivin and VEGF over-expression in NPC tumor tissues were strong independent factors of poor prognosis in NPC patients. The mean AI in the 39 survivin low-expression cases was 144.7 ± 39.9, which was significantly higher than that in 61 survivin over-expression cases (111.6 ± 39.8) (T test, P < 0.05). Conclusion: Survivin and VEGF over-expression are independent prognostic factors for the patients with NPC. These results also suggest that tumor survivin and VEGF expressions are valuable prognostic markers for prognosis prediction in NPC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
VEGF and the quest for tumour angiogenesis factors
Ferrara, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc909 · Cited by 1,536
Cited by
Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
Alkilany, A. M., & Murphy, C. J. (2010) · Journal of Nanoparticle Research · doi:10.1007/s11051-010-9911-8 · Cited by 1,485
Inflammation and cancer: how friendly is the relationship for cancer patients?
Aggarwal, B. B., & Gehlot, P. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.020 · Cited by 405
Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?
Patwardhan, B., & Mashelkar, R. A. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.05.009 · Cited by 390
MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma
Chen, H.-C., Chen, G.-H., Chen, Y.-H., Liao, W.-L., Liu, C.-Y., Chang, K.-P., Chang, Y.-S., & Chen, S.-J. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604948 · Cited by 276
Zhang, Y., Yan, L.-X., Wu, Q.-N., Du, Z.-M., Chen, J., Liao, D.-Z., Huang, M.-Y., Hou, J.-H., Wu, Q.-L., Zeng, M.-S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2435 · Cited by 273
Self-citation
Metadata
- Authors
- Li, Y.-H., Hu, C.-F., Shao, Q., Huang, M.-Y., Hou, J.-H., Xie, D., Zeng, Y.-X., & Shao, J.-Y.
- Venue
- Journal of Translational Medicine
- Published
- 2008-01-03
- Volume
- 6
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1479-5876 (ISSN-L)
- OpenAlex
- W2075796873
- Cited by
- 204
- References
- 2
- FWCI
- 16.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. https://app.cochat.ai/papers/10.1186/1479-5876-6-1
- The paper
- Li, Y.-H., Hu, C.-F., Shao, Q., Huang, M.-Y., Hou, J.-H., Xie, D., Zeng, Y.-X., & Shao, J.-Y. (2008). Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. Journal of Translational Medicine. https://doi.org/10.1186/1479-5876-6-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.